| Original language | English |
|---|---|
| Pages (from-to) | 672-674 |
| Number of pages | 3 |
| Journal | Arteriosclerosis, Thrombosis, and Vascular Biology |
| Volume | 45 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2025 |
Funding
The authors\u2019 research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL155649), a Merit award from the American Heart Association (23MERIT1036341), and an institutional support from the College of Medicine at the University of Kentucky to H.S. Lu. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
| Funders | Funder number |
|---|---|
| National Heart, Lung, and Blood Institute Family Blood Pressure Program | |
| University of Kentucky | |
| National Institutes of Health (NIH) | R35HL155649 |
| National Institutes of Health (NIH) | |
| American the American Heart Association | 23MERIT1036341 |
| American the American Heart Association |
Keywords
- Editorials
- LDL
- atherosclerosis
- cholesterol
- lipoproteins
- liver X receptors
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine